Literature DB >> 28639901

Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.

Lingqi Liu1, Yanqin Li2, Shuchao Liu1, Qixin Duan1, Liang Chen1, Tianpeng Wu1, Huijun Qian1, Sixing Yang1, Dianqi Xin3.   

Abstract

Although miR-193a-3p has been found to be dysregulated in variety of human tumors, little is known about its role in renal cell carcinoma. This study was designed to investigate the function and underlying mechanism of miR-193a-3p in human renal cell carcinoma tissues and cell lines. Here, we demonstrated that the expression of miR-193-3p was increased in renal cell carcinoma tissues and cell lines. In addition, knockdown of miR-193a-3p significantly inhibited cell proliferation and colony formation and induced cells into G1 phase arrest. Meanwhile, the migration potential of 786-O cells was also decreased compared to control group. Furthermore, we identified PTEN as a direct and functional target of miR-193a-3p, at least partly responsible for promoting tumor effect of miR-193a-3p in renal cell carcinoma. Taken together, the findings indicated for the first time that miR-193a-3p functions as a tumor-promoting microRNA by directly targeting PTEN in renal cell carcinoma.

Entities:  

Keywords:  PTEN; miR-193a-3p; migration; proliferation; renal cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28639901     DOI: 10.1177/1010428317711951

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Authors:  Imène Hamaidi; Catherine Coquard; Sabrina Danilin; Valérian Dormoy; Claire Béraud; Sylvie Rothhut; Mariette Barthelmebs; Nadia Benkirane-Jessel; Véronique Lindner; Hervé Lang; Thierry Massfelder
Journal:  Oncogene       Date:  2018-08-03       Impact factor: 9.867

2.  Long non-coding RNA NEAT1/miR-193a-3p regulates LPS-induced apoptosis and inflammatory injury in WI-38 cells through TLR4/NF-κB signaling.

Authors:  Weixin Nong
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2.

Authors:  Lingqi Liu; Liang Chen; Tianpeng Wu; Huijun Qian; Sixing Yang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 4.  MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours.

Authors:  Michele Ghidini; Jens C Hahne; Melissa Frizziero; Gianluca Tomasello; Francesco Trevisani; Andrea Lampis; Rodolfo Passalacqua; Nicola Valeri
Journal:  Target Oncol       Date:  2018-08       Impact factor: 4.493

5.  MiR-193a-3p Promotes Fracture Healing via Targeting PTEN Gene.

Authors:  Kai Zheng; Ying Wang
Journal:  Mol Biotechnol       Date:  2021-04-04       Impact factor: 2.695

Review 6.  The Complex Landscape of PTEN mRNA Regulation.

Authors:  Erin Sellars; Martino Gabra; Leonardo Salmena
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

7.  Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma.

Authors:  Yu-Yuan Qian; Kun Li; Quan-Yan Liu; Zhi-Su Liu
Journal:  Oncotarget       Date:  2017-11-06

8.  Knockdown long noncoding RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal cancer through modulating miR-193a-3p/KRAS.

Authors:  Zhouting Zhu; Shangce Du; Kai Yin; Shichao Ai; Mengchao Yu; Yanqing Liu; Yan Shen; Minghui Liu; Ruihua Jiao; Xi Chen; Wenxian Guan
Journal:  Cancer Med       Date:  2018-12-21       Impact factor: 4.452

9.  Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1.

Authors:  Yue Zhang; Bin Sun; Zhi Huang; Dai-Wei Zhao; Qingfan Zeng
Journal:  Med Sci Monit       Date:  2018-02-01

10.  MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.

Authors:  FeiYan Xie; Sumayyah Hosany; Shen Zhong; Yang Jiang; Fen Zhang; LiLi Lin; XiaoBo Wang; ShenMeng Gao; XiaoQu Hu
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.